Uppsala, Sweden, May 20, 2026. Dicot Pharma AB announces that the company has successfully completed manufacturing of the drug candidate LIB-01 as a tablet for the planned phase 2b study, which is int ...
4d
Dicot Pharma AB: Dicot Pharma publishes prospectus in connection with the forthcoming rights issue
Dicot Pharma AB ("Dicot Pharma" or the "Company") today, on May 19, 2026, publishes an EU Follow-on Prospectus (the "Prospectus") in connection with the rights issue of units, consisting of shares and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results